Cystadenomas of the liver: a spectrum of disease.
OBJECTIVE
To describe the wide variation in presentation of cystadenomas of the liver and to delineate useful tests for diagnosis and effective surgical treatment.


METHODS
A case series.


METHODS
A university-affiliated hospital.


METHODS
Four patients (3 women, 1 man) having cystadenoma of the liver, 2 of whom had associated mesenchymal stroma.


METHODS
Serum and cyst fluid carcinoembryonic antigen (CEA) and CA19-9 levels, type of surgery, morbidity and recurrence rates.


RESULTS
Cyst fluid CEA and CA19-9 levels were elevated. One patient had resection, 2 had complete enucleation and 1 had partial enucleation. There were no deaths. Morbidity included 1 wound infection; there were no biliary fistulas. The patient with partial enucleation had a radiologically confirmed recurrence.


CONCLUSIONS
Analysis of cyst fluid CEA and CA19-9 is useful for diagnosis; besides hepatic resection, complete enucleation should be considered as a reasonable treatment for patients with this disease.
Dixon
E
E
Department of Surgery, Peter Lougheed Hospital, University of Calgary, Alta.
Sutherland
F R
FR
Mitchell
P
P
McKinnon
G
G
Nayak
V
V
D000328:Adult; D018395:CA-19-9 Antigen / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003537:Cystadenoma / Q000175:diagnosis* / Q000601:surgery*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen